These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 30785719)

  • 1. TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral Sclerosis.
    Palomo V; Tosat-Bitrian C; Nozal V; Nagaraj S; Martin-Requero A; Martinez A
    ACS Chem Neurosci; 2019 Mar; 10(3):1183-1196. PubMed ID: 30785719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular neuropathology of TDP-43 proteinopathies.
    Neumann M
    Int J Mol Sci; 2009 Jan; 10(1):232-246. PubMed ID: 19333444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia.
    Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH
    J Neurol Sci; 2016 Jul; 366():197-201. PubMed ID: 27288806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways.
    Barmada SJ; Finkbeiner S
    Rev Neurosci; 2010; 21(4):251-72. PubMed ID: 21086759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia.
    van Blitterswijk M; Baker MC; Bieniek KF; Knopman DS; Josephs KA; Boeve B; Caselli R; Wszolek ZK; Petersen R; Graff-Radford NR; Boylan KB; Dickson DW; Rademakers R
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):463-9. PubMed ID: 23634771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R
    Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity.
    Wang W; Wang L; Lu J; Siedlak SL; Fujioka H; Liang J; Jiang S; Ma X; Jiang Z; da Rocha EL; Sheng M; Choi H; Lerou PH; Li H; Wang X
    Nat Med; 2016 Aug; 22(8):869-78. PubMed ID: 27348499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD.
    Hayes LR; Kalab P
    Neurotherapeutics; 2022 Jul; 19(4):1061-1084. PubMed ID: 35790708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD.
    Shenouda M; Zhang AB; Weichert A; Robertson J
    Adv Neurobiol; 2018; 20():239-263. PubMed ID: 29916022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Bright F; Chan G; van Hummel A; Ittner LM; Ke YD
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological Spectrum of Amyotrophic Lateral Sclerosis Prions.
    Polymenidou M; Cleveland DW
    Cold Spring Harb Perspect Med; 2017 Nov; 7(11):. PubMed ID: 28062558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice.
    Ke YD; van Hummel A; Au C; Chan G; Lee WS; van der Hoven J; Przybyla M; Deng Y; Sabale M; Morey N; Bertz J; Feiten A; Ippati S; Stevens CH; Yang S; Gladbach A; Haass NK; Kril JJ; Blair IP; Delerue F; Ittner LM
    Neuron; 2024 Apr; 112(8):1249-1264.e8. PubMed ID: 38366598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia.
    Pasetto L; Grassano M; Pozzi S; Luotti S; Sammali E; Migazzi A; Basso M; Spagnolli G; Biasini E; Micotti E; Cerovic M; Carli M; Forloni G; De Marco G; Manera U; Moglia C; Mora G; Traynor BJ; Chiò A; Calvo A; Bonetto V
    Brain; 2021 Dec; 144(12):3710-3726. PubMed ID: 34972208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zn
    Preethi S; Bharathi V; Patel BK
    Int J Biol Macromol; 2021 Apr; 176():186-200. PubMed ID: 33577819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology.
    Pozzi S; Thammisetty SS; Codron P; Rahimian R; Plourde KV; Soucy G; Bareil C; Phaneuf D; Kriz J; Gravel C; Julien JP
    J Clin Invest; 2019 Feb; 129(4):1581-1595. PubMed ID: 30667370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.
    Geser F; Martinez-Lage M; Kwong LK; Lee VM; Trojanowski JQ
    J Neurol; 2009 Aug; 256(8):1205-14. PubMed ID: 19271105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology.
    Wegorzewska I; Baloh RH
    Neurodegener Dis; 2011; 8(4):262-74. PubMed ID: 21124004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.